Cervical dystonia, confirming the discriminative value of a new diagnostic method

Cervical dystonia, confirming the discriminative value of a new diagnostic method - cervical dystonia

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON40531

Enrollment

Registered

2013-08-26

Start date

2013-11-29

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical dystonia spasmodic torticollis wry neck

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with idiopatic cervical dystonia Age of onset *26 botulinum toxin treatment naive or last treatment more then 3 months ago Informed consent

Exclusion criteria

Exclusion criteria: Fixed dystonia (often considered a sign of psychogenic torticollis) Secondary dystonia Use of neuropharmaceuticals Pregnancy

Design outcomes

Secondary

Measure	Time frame
The differences in characteristics and distribution of abnormal activation patterns between CD patients and FT patients . Additional outcome in CD patients that are currently receiving BTX treatment: The differences in characteristics and prevalence of abnormal activation patterns before and after botulinum toxin treatment.	—

Primary

Measure	Time frame
The accuracy of the new method in muscle selection. The accuracy will be calculated using the diagnostic odds ratio, sensitivity and specificity.	—

Countries

Netherlands

Outcome results